EP1299530A4 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- EP1299530A4 EP1299530A4 EP01954662A EP01954662A EP1299530A4 EP 1299530 A4 EP1299530 A4 EP 1299530A4 EP 01954662 A EP01954662 A EP 01954662A EP 01954662 A EP01954662 A EP 01954662A EP 1299530 A4 EP1299530 A4 EP 1299530A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21803300P | 2000-07-12 | 2000-07-12 | |
US218033P | 2000-07-12 | ||
US22651700P | 2000-08-21 | 2000-08-21 | |
US226517P | 2000-08-21 | ||
PCT/US2001/021985 WO2002004600A2 (en) | 2000-07-12 | 2001-07-12 | Novel compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1299530A2 EP1299530A2 (en) | 2003-04-09 |
EP1299530A4 true EP1299530A4 (en) | 2005-03-09 |
Family
ID=26912504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01954662A Withdrawn EP1299530A4 (en) | 2000-07-12 | 2001-07-12 | Novel compounds |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1299530A4 (en) |
JP (1) | JP2004502453A (en) |
AU (1) | AU2001276890A1 (en) |
WO (1) | WO2002004600A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002226033A1 (en) | 2000-12-07 | 2002-06-18 | Zymogenetics Inc. | Adipocyte complement related protein zacrp3x2 |
EP1434783A4 (en) * | 2001-03-16 | 2006-06-07 | Lilly Co Eli | Lp mammalian proteins; related reagents |
US20060258567A1 (en) * | 2002-03-29 | 2006-11-16 | Serono Genetics Institite S.A. | Xcrf polynucleotides and polypeptides and uses thereof |
EP1869207A1 (en) * | 2005-04-07 | 2007-12-26 | AstraZeneca AB | METHOD FOR ASSESSING THE PRESDISPOSITION AND/OR SUSCEPTIBILITY TO COPD BY ANALYSING FGF-BPl |
GB0508863D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Peptide |
KR101900016B1 (en) * | 2009-03-12 | 2018-09-20 | 캔서 프리벤션 앤 큐어, 리미티드 | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
-
2001
- 2001-07-12 WO PCT/US2001/021985 patent/WO2002004600A2/en not_active Application Discontinuation
- 2001-07-12 EP EP01954662A patent/EP1299530A4/en not_active Withdrawn
- 2001-07-12 JP JP2002509455A patent/JP2004502453A/en not_active Withdrawn
- 2001-07-12 AU AU2001276890A patent/AU2001276890A1/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
DATABASE EMBL 20 June 1994 (1994-06-20), "Rattus norvegicus mRNA for periaxin, strain Wistar.", XP002305988, retrieved from EBI Database accession no. Z29649 * |
DATABASE EMBL 3 March 1998 (1998-03-03), "Mus musculus mRNA for L-periaxin.", XP002306182, retrieved from EBI Database accession no. AJ222968 * |
GILLESPIE C S ET AL: "Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment.", NEURON. MAR 1994, vol. 12, no. 3, March 1994 (1994-03-01), pages 497 - 508, XP009040111, ISSN: 0896-6273 * |
See also references of WO0204600A3 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002004600A3 (en) | 2002-06-20 |
JP2004502453A (en) | 2004-01-29 |
AU2001276890A1 (en) | 2002-01-21 |
WO2002004600A2 (en) | 2002-01-17 |
EP1299530A2 (en) | 2003-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1276755A4 (en) | Novel compounds | |
GB0003019D0 (en) | Novel compounds | |
AU9261901A (en) | Novel compounds | |
EP1255771A4 (en) | Novel compounds | |
GB0008464D0 (en) | Novel compounds | |
EP1292617A4 (en) | Novel compounds | |
EP1472352A4 (en) | Novel compounds | |
EP1343813A4 (en) | Novel compounds | |
AU7476401A (en) | Novel compounds | |
EP1276866A4 (en) | Novel compounds | |
GB0004149D0 (en) | Novel compounds | |
EP1299530A4 (en) | Novel compounds | |
GB0001898D0 (en) | Novel compounds | |
GB0003636D0 (en) | Novel compounds | |
GB0004196D0 (en) | Novel compounds | |
GB0002402D0 (en) | Novel compounds | |
EG22332A (en) | Novel compounds | |
GB0004071D0 (en) | Novel compounds | |
GB0002195D0 (en) | Novel compounds | |
GB0004188D0 (en) | Novel Compounds | |
GB0004186D0 (en) | Novel Compounds | |
GB0004414D0 (en) | Novel compounds | |
GB0004917D0 (en) | Novel compounds | |
GB0005256D0 (en) | Novel compounds | |
GB0003112D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030117 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 12N 15/63 B Ipc: 7C 07K 14/705 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050120 |
|
17Q | First examination report despatched |
Effective date: 20050411 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20051022 |